MedPath

effect of probiotic in cirrhosis patients

Phase 3
Recruiting
Conditions
Cirrhosis.
Fibrosis and cirrhosis of liver
Registration Number
IRCT20190306042944N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

cirrhosis with any reasons
Age above 18

Exclusion Criteria

Chronic physical or sychiatric illness
Encephalopathy
Active infection
Addiction
Intake immunosuppressive drugs
Patient Dissatisfaction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life in cirrhosis patients. Timepoint: At the beginning of the study and 3 months later (end of the study). Method of measurement: According to the quality of life questionnaire for chronic liver patients (CLDQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath